T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects Meeting Abstract


Authors: Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; Houghton, S.; Betof, A.; Panageas, K.; Lacuoture, M.; Hollmann, T.; Albrengues, J.; Egeblad, M.; Merghoub, T.; Wolchok, J.
Abstract Title: T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
Meeting Title: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 6
Issue: Suppl. 1
Meeting Dates: 2018 Nov 7-11
Meeting Location: Washington, DC
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2018-11-06
Start Page: 115
Language: English
PMCID: PMC6220479
PUBMED: 30400822
DOI: 10.1186/s40425-018-0423-x
PROVIDER: manual
Notes: Meeting Abstract: P521 -- Mario Lacouture's last name and Travis Hollmann's first name were misspelled on the original publication
Altmetric
Citation Impact
BMJ Impact Analytics